Cargando…

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk

Obstructive sleep apnoea (OSA) syndrome is characterised by the presence of apnoea or obstructive hypopnoea during sleep, accompanied by hypoxia. It is estimated that the syndrome affects approximately 10% of men and 15% of women. Diagnosis and treatment rates have increased in recent years, but the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Resano-Barrio, María Pilar, Arroyo-Espliguero, Ramón, Viana-Llamas, María Carmen, Mediano, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2020
Materias:	Management and Comorbidities
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539148/ https://www.ncbi.nlm.nih.gov/pubmed/33042228 http://dx.doi.org/10.15420/ecr.2020.10

Ejemplares similares

Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Obstructive Sleep Apnoea in Patients with Cardiovascular Disease
por: Tan, Jack Wei Chieh, et al.
Publicado: (2022)

Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity
por: Biskup, Małgorzata, et al.
Publicado: (2018)

Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS‐HF and RALES
por: Yeoh, Su E., et al.
Publicado: (2021)

Kawasaki Disease: A Never-ending Story?
por: Lianza, Alessandro Cavalcanti, et al.
Publicado: (2023)

Factors Related to Maternal Adverse Outcomes in Pregnant Women with Cardiac Disease in Low-resource Settings
por: Poli, Philippe Amubuomombe, et al.
Publicado: (2020)

Bridging the Gap in a Rare Cause of Angina
por: Khadke, Sumanth, et al.
Publicado: (2021)

Scoring Systems to Predict Survival or Neurological Recovery after Out-of-hospital Cardiac Arrest
por: Naik, Rishi, et al.
Publicado: (2022)

Effects of continuous positive airway pressure on depression and anxiety symptoms in patients with obstructive sleep apnoea: results from the sleep apnoea cardiovascular Endpoint randomised trial and meta-analysis
por: Zheng, Danni, et al.
Publicado: (2019)

Evolution of tricuspid regurgitation after transcatheter edge‐to‐edge mitral valve repair for secondary mitral regurgitation and its impact on mortality
por: Adamo, Marianna, et al.
Publicado: (2022)

Continuous Positive Airway Pressure: Is it a route for infection in those with Obstructive Sleep Apnoea?
por: Mercieca, Liam, et al.
Publicado: (2017)

Predictive equation for optimal continuous positive airway pressure in children with obstructive sleep apnoea
por: Chong, Joelle, et al.
Publicado: (2020)

Are symptoms of obstructive sleep apnoea related to good continuous positive airway pressure compliance?
por: Kaewkes, Chaiwat, et al.
Publicado: (2020)

Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF
por: Butt, Jawad H., et al.
Publicado: (2021)

Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial
por: Filippatos, Gerasimos, et al.
Publicado: (2013)

Cardiopulmonary factors affecting 6-min walk distance in patients with idiopathic inflammatory myopathies
por: Mugii, Naoki, et al.
Publicado: (2018)

Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017
por: Lindner, Lisa, et al.
Publicado: (2020)

Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome
por: Traianos, Emmanuella Young, et al.
Publicado: (2020)

Self-reported fatigue in patients with rheumatoid arthritis compared to patients with cancer: results from two large-scale studies
por: Müller, Karolina, et al.
Publicado: (2021)

The association between type 2 diabetes and anhedonic subtype of major depression in hypertensive individuals
por: Willame, Hadrien, et al.
Publicado: (2022)

Analysis of integrated clinical safety data of tadalafil in patients receiving concomitant antihypertensive medications
por: Kloner, Robert A., et al.
Publicado: (2022)

Tadalafil in patients on antihypertensive medications: Does safety remain an issue?
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

The role of tadalafil in treated hypertensive patients with erectile dysfunction
por: Grossman, Ehud
Publicado: (2022)

The Effect of Iron Deficiency on Cardiac Function and Structure in Heart Failure with Reduced Ejection Fraction
por: Martens, Pieter
Publicado: (2022)

The Impact of Frailty and Comorbidities on Heart Failure Outcomes
por: Salmon, Thomas, et al.
Publicado: (2022)

The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis
por: van den Oever, I. A. M., et al.
Publicado: (2020)

Hyperkalaemia in Heart Failure
por: Ismail, Umar, et al.
Publicado: (2021)

Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction
por: Jackson, Alice M., et al.
Publicado: (2022)

Urinary peptides in heart failure: a link to molecular pathophysiology
por: He, Tianlin, et al.
Publicado: (2021)

Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study
por: Alnuwaysir, Ridha I.S., et al.
Publicado: (2021)

Cardiovascular risk and mortality in patients with hyperuricemia treated with febuxostat or allopurinol: a retrospective nation-wide cohort study in Austria 2014–2017
por: Weisshaar, Stefan, et al.
Publicado: (2022)

The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study
por: Rosenkranz, Stephan, et al.
Publicado: (2021)

Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence
por: Janse, Roemer J., et al.
Publicado: (2022)

Continuous Positive Airway Pressure Treatment: Effect on Serum Lipids in Patients with Obstructive Sleep Apnoea
por: Michailidis, Vassileios, et al.
Publicado: (2011)

Continuous positive airway pressure adherence declines with age in elderly obstructive sleep apnoea patients
por: Martinez-Garcia, Miguel Angel, et al.
Publicado: (2019)

Nasal Symptoms in Patients with Obstructive Sleep Apnoea and Their Association with Continuous Positive Airway Pressure Usage
por: Chaidas, Konstantinos, et al.
Publicado: (2022)

Extrapulmonary effects of continuous airway pressure on patients with obstructive sleep apnoea: protocol for an overview of systematic reviews
por: Labarca, Gonzalo, et al.
Publicado: (2017)

Prevalence of obstructive sleep apnoea in REM behaviour disorder: response to continuous positive airway pressure therapy
por: Gabryelska, A., et al.
Publicado: (2017)

Impact of COVID-19 lockdown on adherence to continuous positive airway pressure by obstructive sleep apnoea patients
por: Attias, David, et al.
Publicado: (2020)

Treatment burden experienced by patients with obstructive sleep apnoea using continuous positive airway pressure therapy
por: Chou, Michael S. H., et al.
Publicado: (2021)

Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment
por: Del Ben, Maria, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_479t9n2ejsnlb76ife7mrks9ht